Literature DB >> 28336350

Smoking as a Risk Factor for the Occurrence of Atrial Fibrillation in Men Versus Women: A Meta-Analysis of Prospective Cohort Studies.

Qing Wang1, Yibin Guo2, Cheng Wu2, Liang Yin1, Wei Li1, Hua Shen1, Wang Xi1, Tianyi Zhang2, Jia He3, Zhinong Wang4.   

Abstract

BACKGROUND: Although smoking is known to be associated with cardiovascular diseases, the number of large-scale cohort studies on the association between smoking and atrial fibrillation (AF) is limited and the results obtained are also inconsistent, and even fewer studies have addressed the difference between the male and female genders. The present study was intended to clarify and quantify the association between smoking and the risk of AF in men versus women.
METHODS: Using AF- and smoking-related keywords, a comprehensive literature search on PubMed, Embase and Web of Science was conducted with a time limit until December 2016, which was followed by manual screening, quality assessment and data extraction. The pooled relative risk (RR) of the included studies was estimated by using the random-effects model. Subgroup, heterogeneity and sensitivity analyses were also conducted.
RESULTS: A total of 14 prospective studies and 222,159 individuals were included in this meta-analysis, and the pooled RR of the 14 studies was 1.24 (95% CI, 1.12-1.36; p<0.0001) for the occurrence of AF in smoking populations. The pooled RR in men was 1.38 (95% CI, 1.21-1.57 p<0.0001) versus 1.28 in women (95% CI, 0.93-1.76; p=0.1356). The male-to-female ratio of relative risk (RRR) was 1.17 (95% CI, 0.84-1.63; p=0.3418) of smoking versus non-smoking individuals.
CONCLUSION: Smoking is a risk factor for the occurrence of AF. Compared with women, male smokers are more likely to develop AF.
Copyright © 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Gender difference; Risk factors; Smoking

Mesh:

Year:  2017        PMID: 28336350     DOI: 10.1016/j.hlc.2017.01.021

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  3 in total

1.  Ticagrelor Use in Acute Myocardial Infarction: Balancing Evidence-Based Medicine with Affordability.

Authors:  Andrew L Walker; Teshia Sorensen; Paolo P Gabriel; Tyler Sledge; Jack H Morshedzadeh; Theophilus Owan; Rashmee U Shah
Journal:  J Am Coll Clin Pharm       Date:  2018-04-14

2.  Provider-Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry.

Authors:  Mayank Sardana; Yuanyuan Tang; Jared W Magnani; Ira S Ockene; Jeroan J Allison; Suzanne V Arnold; Phillip G Jones; Thomas M Maddox; Salim S Virani; David D McManus
Journal:  J Am Heart Assoc       Date:  2019-06-28       Impact factor: 5.501

Review 3.  Harmful Impact of Tobacco Smoking and Alcohol Consumption on the Atrial Myocardium.

Authors:  Amelie H Ohlrogge; Lars Frost; Renate B Schnabel
Journal:  Cells       Date:  2022-08-18       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.